Cover Image
市場調查報告書

新興國家(巴西,俄羅斯,印度,中國,南非,韓國的)人工心臟瓣膜市場

Prosthetic Heart Valves - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

出版商 Axis Research Mind 商品編碼 307196
出版日期 內容資訊 英文 481 Pages; 106 Tables/Charts
商品交期: 最快1-2個工作天內
價格
Back to Top
新興國家(巴西,俄羅斯,印度,中國,南非,韓國的)人工心臟瓣膜市場 Prosthetic Heart Valves - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
出版日期: 2014年06月30日 內容資訊: 英文 481 Pages; 106 Tables/Charts
簡介

新興市場(巴西、俄羅斯、印度、中國、南非、韓國)的人工心臟瓣膜市場預測到2016年前將達到4億6,800萬美元。中國約佔全球市場的26%,印度以20%次之。各產品方面,機械瓣膜市場預測將佔約50%的佔有率。

本報告提供上述新興市場中人工心臟瓣膜市場的相關調查,彙整市場最新趨勢與今後預測,加入此市場的主要企業簡介與策略性活動等。

第1章 報告的焦點

  • 簡介
  • 心血管設備
  • 人工心臟瓣膜
    • 機械瓣膜
    • 生物/組織瓣膜
    • 經導管心臟瓣膜
  • 人工心臟瓣膜:市場概要
    • 中國
    • 印度
    • 巴西
    • 俄羅斯
    • 韓國
    • 南非

第2章 市場分析

  • 人工心臟瓣膜:產業概要
  • 人工心臟瓣膜:市場區隔
  • 人工心臟瓣膜:全球
  • 人工心臟瓣膜:BRICSS各國
  • 人工心臟瓣膜:各類型
    • 機械瓣膜
    • 生物/組織瓣膜
    • 經管導管心臟瓣膜
  • 成長率分析
  • 投資的焦點

第3章 產業概要

  • 心臟各醫療設備檢討
    • 心律管理設備
    • 心臟整流去顫器
    • 心律調節器
    • 心臟再同步化治療
    • 心臟監測·診斷設備
    • 介入性心臟設備
    • 心導管
    • 電生理學導管
    • EP MAPPING
    • 心房纖維顫動
    • 血管內超音波
    • 末梢血管設備
    • 末梢血管導管導引線
    • 人工心臟瓣膜
  • 心臟設備:死亡率風險與年齡
  • 心臟疾病:經濟預測
  • 非洲等方面的感染和心血管疾病
  • 心血管設備近幾年的FDA措施與認證
  • 市場趨勢
  • 主要企業簡介

第4章 產業參與企業資料庫

第5章 附錄

圖表

目錄
Product Code: ARMMR124N.1

“Getting the Most from Our Research Analysis”

The Cardiac Prosthetic Heart Valves market value is expected to reach US$468 million by 2016, primarily supported by the product types - Mechanical Heart Valves, Transluminal Heart Valves and Tissue Heart Valves. China accounts for nearly 26% of the market share and India claims more than 20% of the total share. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Mechanical Heart Valves account nearly half of the market value while Tissue Heart Valves and Transluminal Heart Valves segments add up to the remaining share.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

SEGMENTATION - By TYPE

  • MECHANICAL HEART VALVES
    • a. PERCUTANEOUS IMPLANTATION STENT FRAMED STENT NON-FRAMED
    • b. STERNOTOMY/THORACOTOMY IMPLANTATION BI-LEAFLET TILTING DISK BALL AND CAGE TRI-LEAFLET
  • BIO-PROSTHETIC/TISSUE HEART VALVES &
    • b. HETEROGRAFTS/XENOGRAFT
    • c. HOMOGRAFTS/ALLOGRAFT/ISOGRAFT/AUTOGRAFTS
  • TRANSLUMINAL / NON-INVASIVE HEART VALVES
    • a. EXCHANGEABLE HEART VALVE (WITHOUT STENT)
    • b. EXPANDABLE HEART VALVE

REPORT FOCUS

“Learn High Potential Market Dynamics for Strategic Business Planning”

The report ‘Prosthetic Heart Valves - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

The report focuses on the current market trends, estimates and forecasts for the period 2012-2018. More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 106 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

KEY COMPANIES PROFILED

ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD., ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP INCORPORATED, DRÄGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC., MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more...

GEOGRAPHIC COVERAGE

The region-wise distribution consists of Emerging Markets (Brazil, Russia, India, China, South Africa & South Korea) analyzed individually.

BRICSS PROSTHETIC HEART VALVES - MARKET SHARE
BY GEOGRAPHY & BY TYPE - 2015-%

Table of Contents

I. REPORT FOCUS

  • A. INTRODUCTION
  • CARDIOLOGY
  • KINDS OF CARDIAC CONDITIONS
  • A. BLOOD FLOW IN THE HEART
  • B. HEART MALFUNCTION
  • TYPES OF CARDIAC ARREST
  • C. MYOCARDIUM
  • DISORDERS OF MYOCARDIUM
  • D. PERICARDIUM
  • E. HEART VALVES
  • DISORDERS OF HEART VALVES
  • F. CONGENITAL HEART DEFECT
  • TYPES OF CONGENITAL HEART DEFECT
  • G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)
  • H. HEART FAILURE
  • B. CARDIOVASCULAR DEVICES
  • DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
  • TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
  • TOOLS DEPLOYED IN CARDIOLOGY
  • DIAGNOSTIC TESTS AND PROCEDURES
  • CONCLUSION
  • C. PROSTHETIC HEART VALVES
  • KINDS OF VALVE DISEASE
  • A. VALVE STENOSIS
  • B. VALVE SHORTAGE

I. MECHANICAL HEART VALVES

  • STRENGTHS
  • WEAKNESSES
  • MECHANICAL HEART VALVES - TYPES
  • A. CAGED BALL MODEL
  • B. TILTING DISC
  • C. BILEAFLET VALVE

II. BIO-PROSTHETIC/TISSUE HEART VALVES

  • BENEFITS
  • DETRIMENTS
  • ILLUSTRATION
  • CONCLUSION
  • TISSUES - SOURCES
  • BIOPROSTHETIC VALVES - PROPERTIES
  • TYPES
  • A. STENTED BIOPROSTHESES
  • B. STENTLESS BIOPROSTHESES
  • C. PERCUTANEOUS BIOPROSTHESES
  • MECHANICAL VALVES VS. BIO-PROSTHETIC VALVES

IV. TRANSLUMINAL CATHETER EMBEDDED PROSTHETIC HEART VALVES

  • IMPLANTS
  • LOCATION
  • PROCEDURE
  • D. PROSTHETIC HEART VALVES - TYPES - MARKET BRIEFING
  • CHINA
  • INDIA
  • BRAZIL
  • RUSSIA
  • SOUTH KOREA
  • SOUTH AFRICA

II. MARKET ANALYSIS

  • PROSTHETIC HEART VALVES - BRICSS - INDUSTRY SNAPSHOT
  • A. PROSTHETIC HEART VALVES - SEGMENTATION
  • PROSTHETIC HEART VALVES - GLOBAL
  • PROSTHETIC HEART VALVES - BRICSS
  • PROSTHETIC HEART VALVES - BY TYPE
  • PROSTHETIC HEART VALVES - BRICSS
  • MECHANICAL HEART VALVES
  • BIO-PROSTHETIC HEART VALVES
  • TRANSLUMINAL HEART VALVES
  • B. GROWTH RATE ANALYSIS
  • BRICSS PROSTHETIC HEART VALVES - MARKET GROWTH RATES
  • BRICSS PROSTHETIC HEART VALVES - TYPE - GROWTH RATES
  • C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

  • FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
  • AN ENCOURAGING JAB FOR TORPID PERIODS
  • A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
  • CARDIAC RHYTHM MANAGEMENT DEVICES
  • CRM IN EUROPE
  • CARDIAC DEFIBRILLATORS
  • RAPID GROWTH IN DEFIBRILLATOR SALES
  • CARDIAC PACEMAKER DEVICES
  • THE DATA COLLECTION WORK
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT)
  • CARDIAC MONITORING AND DIAGNOSTIC DEVICES
  • THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
  • INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
  • THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW
  • INTERVENTIONAL CARDIAC DEVICES
  • CORONARY STENTS
  • EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION
  • FFR IMPACT ON DES MARKET
  • MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET
  • CARDIAC CATHETERS
  • COMPETITIVE ANALYSIS
  • ELECTROPHYSIOLOGY CATHETERS (EP)
  • GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
  • DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH
  • EP MAPPING
  • NEW AF ABLATION DEVICES SEEK APPROVAL
  • ATRIAL FIBRILLATION (AF)
  • INTRAVASCULAR ULTRASOUND (IVUS)
  • GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
  • PERIPHERAL VASCULAR DEVICES
  • ARTERIOTOMY CLOSURE DEVICES
  • EMBOLIC PROTECTION DEVICES (EPD)
  • INFERIOR VENA CAVA (IVC) FILTERS
  • CONCLUSION
  • PERIPHERAL GUIDEWIRES
  • AV ACCESS THROMBECTOMY DEVICES
  • PROSTHETIC HEART VALVES
  • SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
  • MARKET CHALLENGES
  • B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
  • DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
  • SIZE AND WEIGHT
  • POWER EFFICIENCY
  • PERFORMANCE SPECIFICATIONS
  • RISK MITIGATION AND RELIABILITY
  • EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES
  • C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
  • CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
  • IMPACT OF CVD IN EUROPE
  • IMPACT ON NEW YORK STATE
  • ECONOMIC IMPACT OF CVD IN NYS
  • HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
  • IMPACT OF CVD ON ECONOMIC STABILITY
  • ECONOMIC COST OF CARDIOVASCULAR DISEASES
  • COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
  • CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE
  • D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND
  • E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES
  • F. MARKET TRENDS
  • PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
  • CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
  • GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
  • GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
  • CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
  • INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
  • TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
  • INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
  • STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
  • GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
  • MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
  • B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
  • MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
  • RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
  • A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
  • ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
  • SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
  • FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
  • AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
  • SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
  • USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
  • MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.
  • MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
  • DRUG-ELUTING STENTS ARE SECURE
  • CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
  • ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
  • ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
  • ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
  • BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
  • HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
  • FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
  • FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
  • BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
  • COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
  • MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
  • MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
  • NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
  • FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
  • STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
  • USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
  • SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
  • TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
  • CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
  • SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
  • EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
  • ZOLL NOMINATED TO GLOBE 100 AGAIN
  • USCOM ENTERS EUROPEAN MARKETS
  • POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
  • USCOM SECURES STRONG PRESENCE IN US AND CANADA
  • CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
  • COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
  • STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
  • SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
  • CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
  • USCOM EYES EASTERN EUROPEAN MARKET
  • VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
  • INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
  • INFECTIONS FROM IMPLANTED CARDIAC DEVICES
  • TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
  • HEART TRANSPLANTS SUBSTITUTED BY A PUMP
  • DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
  • REMOTE MONITORING OF HEART FAILURE PATIENTS
  • EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
  • OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
  • IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
  • OVER-THE-COUNTER APPARATUS
  • BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
  • CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
  • THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
  • CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
  • LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
  • A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
  • A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
  • LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
  • INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
  • BEST AND LATEST SELF-TEACHING HEART SOUNDS
  • REPLACING VALVE WITHOUT CARDIAC SUPPORT
  • U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
  • AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
  • NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
  • MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS
  • G. KEY COMPANY PROFILES
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD
  • OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES
  • CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • CARDIAC MEDICAL DEVICES - PATENTS
  • KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

  • RESEARCH FOCUS
  • ABOUT AXIS RESEARCH MIND
  • DISCLAIMER
  • FEEDBACK

LIST OF TABLES/CHARTS

I. REPORT FOCUS

  • 1. MAJOR COMPANIES PRODUCTS IN THE CURRENT MARKET
  • D. PROSTHETIC HEART VALVES - TYPES - MARKET BRIEFING

CHINA

  • 2. PROSTHETIC HEART VALVES MARKET - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES FOR CHINA -(2012-2018, IN USD$ MILLION)
  • 3. PROSTHETIC HEART VALVES - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF CHINESE MARKET VALUE - (2015 - 2018)

INDIA

  • 4. PROSTHETIC HEART VALVES MARKET - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES FOR INDIA - (2012-2018, IN USD$ MILLION)
  • 5. PROSTHETIC HEART VALVES - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF INDIAN MARKET VALUE - (2015 - 2018)

BRAZIL

  • 6. PROSTHETIC HEART VALVES MARKET - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES FOR BRAZIL - (2012-2018, IN USD$ MILLION)
  • 7. PROSTHETIC HEART VALVES - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF BRAZILIAN MARKET VALUE - (2015 - 2018)

RUSSIA

  • 8. PROSTHETIC HEART VALVES MARKET - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES FOR RUSSIA - (2012-2018, IN USD$ MILLION)
  • 9. PROSTHETIC HEART VALVES - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF RUSSIA MARKET VALUE - (2015 - 2018)

SOUTH KOREA

  • 10. PROSTHETIC HEART VALVES MARKET - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
  • 11. PROSTHETIC HEART VALVES - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)

SOUTH AFRICA

  • 12. PROSTHETIC HEART VALVES MARKET - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 13. PROSTHETIC HEART VALVES - TYPES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF SOUTH AFRICA MARKET VALUE - (2015 - 2018)
  • 14. PROSTHETIC HEART VALVES - PRODUCT BY BRANDS

II. MARKET ANALYSIS

  • 15. BRICSS PROSTHETIC HEART VALVES - SEGMENTATION BY TYPES

PROSTHETIC HEART VALVES - GLOBAL

  • 16. PROSTHETIC HEART VALVES MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 17. PROSTHETIC HEART VALVES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)

PROSTHETIC HEART VALVES - BRICSS

  • 18. PROSTHETIC HEART VALVES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 19. PROSTHETIC HEART VALVES MARKET - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

PROSTHETIC HEART VALVES - BY TYPE

  • 20. PROSTHETIC HEART VALVES MARKET - MECHANICAL HEART VALVES, BIO-PROSTHETIC HEART VALVES AND TRANSLUMINAL HEART VALVES FOR BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 21. PROSTHETIC HEART VALVES - MECHANICAL HEART VALVES, BIO-PROSTHETIC HEART VALVES AND TRANSLUMINAL HEART VALVES - % OF BRICSS MARKET VALUE - (2015-2018)

PROSTHETIC HEART VALVES - BRICSS

  • MECHANICAL HEART VALVES
  • 22. MECHANICAL HEART VALVES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 23. MECHANICAL HEART VALVES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

BIO-PROSTHETIC HEART VALVES

  • 24. BIO-PROSTHETIC HEART VALVES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 25. BIO-PROSTHETIC HEART VALVES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

TRANSLUMINAL HEART VALVES

  • 26. TRANSLUMINAL HEART VALVES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 27. TRANSLUMINAL HEART VALVES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

B. GROWTH RATE ANALYSIS

  • BRICSS PROSTHETIC HEART VALVES - MARKET GROWTH RATES
  • 28. PROSTHETIC HEART VALVES MARKET - BRICSS- % GROWTH RATE FORECASTS - (2012-2018)

BRICSS PROSTHETIC HEART VALVES - TYPE - GROWTH RATES

  • 29. PROSTHETIC HEART VALVES - % GROWTH RATE FORECASTS FOR MECHANICAL HEART VALVES, BIO-PROSTHETIC HEART VALVES AND TRANSLUMINAL HEART VALVES - (2012-2018)

C. INVESTMENT FOCUS

  • 30. PROSTHETIC HEART VALVES - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 31. PROSTHETIC HEART VALVES - MECHANICAL HEART VALVES, TISSUE HEART VALVES AND TRANSLUMINAL HEART VALVES - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW

  • 32: INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 33: INTRAVENOUS DIAGNOSTICS - BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 34. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
  • 35. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
  • 36. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
  • 37. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
  • 38. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 39. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 40. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
  • 41. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
  • 42. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
  • 43. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • 44. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 45. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
  • 46. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 47. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
  • 48. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)
  • 49. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)
  • 50. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 51. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
  • 52. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ '000)
  • 53. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 54. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
  • 55. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
  • 56. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)
  • 57. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 58. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)
  • 59. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
  • 60. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 61. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 62. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
  • 63. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 64. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
  • 65. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 66. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 67. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 68. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 69. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 70. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
  • 71. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
  • 72. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 73. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 74. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 75. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
  • 76. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)
  • 77. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 78. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
  • 79. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 80. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
  • 81. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)
  • 82. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
  • 83. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
  • 84. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
  • 85. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 86. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 87. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 88. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 89. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 90. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
  • 91. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 92. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 93. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 94. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
  • 95. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)
  • 96. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
  • 97. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 98. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
  • 99. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
  • 100. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)
  • 101. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
  • 102. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
  • 103. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
  • 104. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
  • 105. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
  • 106. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘¥' YEN)

KEY COMPANY PROFILES

NORTH AMERICA

  • ALERE, INC.
  • CARDIOROBOTICS, INC.
  • INTERFACE BIOLOGICS, INC.
  • MERIDIAN HEALTH SYSTEM, INC
  • CARDIVA MEDICAL, INC.
  • LOMBARD MEDICAL TECHNOLOGIES PLC
  • DELTEX MEDICAL GROUP PLC
  • BIOTELEMETRY, INC.
  • BIOHEART, INC.
  • ASAHI INTECC CO., LTD.
  • ANGIODYNAMICS, INC.
  • MERIT MEDICAL SYSTEMS, INC.
  • MOLECULAR DEVICES, LLC
  • ACCELLENT, INC.
  • MEDTRONIC, INC.
  • ABBOTT VASCULAR DEVICES
  • CAMBRIDGE HEART, INC.
  • GREATBATCH, INC.
  • ABIOMED, INC.
  • ADVANSOURCE BIOMATERIALS CORPORATION
  • ATRICURE, INC.
  • ATRIUM MEDICAL CORPORATION
  • BIOPHAN TECHNOLOGIES, INC.
  • BIOSENSE WEBSTER, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • CARDIAC SCIENCE CORPORATION
  • CARDIACASSIST, INC.
  • CARDICA, INC.
  • COOK GROUP INCORPORATED
  • CORDIS CORPORATION
  • CRYOLIFE INC.
  • MAQUET GMBH & CO. KG
  • DIGIRAD CORPORATION
  • EDWARDS LIFESCIENCES, LLC.
  • ENDOLOGIX INCORPORATED
  • ISSYS SENSING SYSTEMS, INC
  • APTUS ENDOSYSTEMS, INC.
  • FLUXION
  • JOHNSON & JOHNSON
  • KONINKLIJKEDSM N.V.
  • MEDRAD, INC.
  • BIOCLINICA
  • MILLAR INSTRUMENTS, INC
  • MONEBO TECHNOLOGIES, INC.
  • MORTARA INSTRUMENT, INC.
  • SIEMENS MEDICAL SOLUTIONS USA, INC.
  • SONOSITE, INC.
  • SORIN GROUP USA, INC.
  • ST. JUDE MEDICAL
  • STEREOTAXIS, INC.
  • TELEFLEX, INC.
  • CARDIOVASCULARSYSTEMS, INC.
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • TERUMO HEART, INC.
  • THORATEC CORPORATION
  • VICOR TECHNOLOGIES, INC.
  • VOLCANO CORPORATION
  • COMPUMED, INC.
  • PULSION MEDICAL SYSTEMS SE
  • 3M HEALTHCARE
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON & CO.
  • NOVADAQ TECHNOLOGIES INC.
  • SCOTTCARE CARDIOVASCULAR SOLUTIONS
  • VARIAN MEDICAL SYSTEMS, INC.
  • THERMEDICS, INC.
  • LEVITRONIX, LLC
  • SUNSHINE HEART, INC.
  • ACCUTECH, LLC
  • ASH ACCESS TECHNOLOGY, INC.
  • C. R. BARD, INC.
  • CONMED CORPORATION
  • HOSPIRA, INC.
  • SURGICAL SPECIALISTIES CORPORATION
  • CARDIUM THERAPEUTICS, INC.
  • CIRCULITE, INC.
  • CARDIOCOMM SOLUTIONS, INC.

EUROPE

  • BERLIN HEART GMBH
  • ESAOTE S.P.A
  • SOPHION BIOSCIENCE A/S
  • BIOTRONIK GMBH & CO. KG.
  • DRÄGER MEDICAL AG & CO. KG
  • BIOTEQUE CORPORATION
  • SPECTRANETICS INTERNATIONAL B.V
  • AORTECH INTERNATIONAL, PLC.
  • APC CARDIOVASCULAR, LTD.
  • ARTERIAL REMODELING TECHNOLOGIES
  • GE HEALTHCARE
  • LIDCO GROUP PLC
  • PHILIPS MEDICAL SYSTEMS
  • SMITH & NEPHEW PLC
  • VASCULAR CONCEPTS
  • AMBU A/S
  • FLEMING MEDICAL LIMITED
  • COVIDIEN PLC

ASIA-PACIFIC

  • NIHON KOHDEN CORPORATION
  • ALL PRO CORPORATION
  • FUKUDA DENSHI CO., LTD.
  • SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD
  • SYNCARDIA SYSTEMS, INC.
  • MICROPORTS MEDICAL
  • LEPU MEDICAL
  • BEIJING ANZHEN HOSPITAL
  • FUDAN UNIVERSITY ZHONGSHAN HOSPITAL
  • INDRAPRASTHA APOLLO HOSPITAL
  • SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD.
  • OPTO CIRCUITS INDIA LIMITED
  • ASAHI KASEI CORPORATION
  • ASIAN HEART INSTITUTE
  • NARAYANA HRUDAYALAYA
  • USCOME LIMITED
  • HEARTWARE LTD.
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • ATCOR MEDICAL HOLDINGS LIMITED
  • CATHRX LTD
  • TTK HEALTHCARE
  • GOODMAN CO., LTD.

REST OF WORLD

  • INSPIREMD LTD.
  • ITGI MEDICAL LTD.
  • MEDINOL, LTD.
  • GAMIDA CELL LTD.
  • AEROTEL MEDICAL SYSTEMS, LTD.
Back to Top